Indices of apoptosis and proliferation as potential prognostic markers in non-functioning pituitary adenomas

Clinical Neuropathology

Volumn 23, Issue 1, 2004, Pages 8-15

  Ibrahim, A E K ^a,c   Pickering, R M ^b   Gawne Cain, M L ^a   King, S ^a   Lees, P D ^a   Ellison, D W ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Apoptosis; Non functioning pituitary adenoma; Proliferation

Indexed keywords

BIOLOGICAL MARKER; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY M 30; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY LABELING; APOPTOSIS; ARTICLE; CANCER INVASION; CELL LABELING; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS; TUMOR GROWTH;

ADENOMA; ADULT; AGED; APOPTOSIS; CELL DIVISION; FEMALE; HUMANS; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 0842269848     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Alvaro V, Levy L, Dubray C, Roche A, Peillon F, Querat B, Joubert D 1993 Invasive human pituitary tumors express a point-mutated alpha-protein kinase-C. J Clin Endocrinol Metab 77: 1125-1129
2. Amar AP, Hinton DR, Krieger MD, Weiss MH 1999 Invasive pituitary adenomas: significance of proliferation parameters. Pituitary 2: 117-122
3. Atkin SL, Green VL, Hipkin LJ, Landolt AM, Foy PM, Jeffreys RV, White MC 1997 A comparison of proliferation indices in human anterior pituitary adenomas using formalin-fixed tissue and in vitro cell culture. J Neurosurg 87: 85-88
4. Bouzubar N, Walker KJ, Griffiths K, Ellis IO, Elston CW, Robertson JF, Blamey RW, Nicholson RI 1989 Ki67 immunostaining in primary breast cancer: pathological and clinical associations. Br J Cancer 59: 943-947
5. Brada M, Ford D, Ashley S, Bliss JM, Crowley S, Mason M, Rajan B, Traish D 1992 Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma. BMJ 304: 1343-1346
6. Brada M, Rajan B, Traish D, Ashley S, Holmes-Sellors PJ, Nussey S, Uttley D 1993 The long-term efficacy of conservative surgery and radiotherapy in the control of pituitary adenomas. Clin Endocrinol (Oxf) 38: 571-578
7. Buchfelder M, Fahlbusch R, Adams EF Kiesewetter F, Thierauf P 1996 Proliferation parameters for pituitary adenomas. Acta Neurochir (Wien) 65 (Suppl): 18-21
8. Carboni P Jr, Detta A, Hitchcock ER, Postans R 1992 Pituitary adenoma proliferative indices and risk of recurrence. Br J Neurosurg 6: 33-40
9. Chun M, Masko GB, Hetelekidis S 1988 Radiotherapy in the treatment of pituitary adenomas. Int J Radiat Oncol Biol Phys 15: 305-309
10. Ciric I, Mikhael M, Stafford T, Lawson L, Garces R 1983 Transsphenoidal microsurgery of pituitary macroadenomas with long-term follow-up results. J Neurosurg 59: 395-401
11. Daita G, Yonemasu Y 1996 Dural invasion and proliferative potential of pituitary adenomas. Neurol Med Chir (Tokyo) 36: 211-214
12. van Diest PJ, Brugal G, Baak JP 1998 Proliferation markers in tumors: interpretation and clinical value. J Clin Pathol 51: 716-724
13. Ebersold MJ, Quast LM, Laws ER Jr, Scheithauer B, Randall RV 1986 Long-term results in transsphenoidal removal of non-functioning pituitary adenomas. J Neurosurg 64: 713-719
14. Ekramullah SM, Saitoh Y, Arita N, Ohnishi T, Hayakawa T 1996 The correlation of Ki-67 staining indices with tumor doubling times in regrowing non-functioning pituitary adenomas. Acta Neurochir (Wien) 138: 1449-1455
15. Gandour-Edwards R, Kapadia SB, Janecka IP, Martinez AJ, Barnes L 1995 Biologic markers of invasive pituitary adenomas involving the sphenoid sinus. Mod Pathol 8: 160-164
16. Gavrieli Y, Sherman Y, Ben Sasson SA 1992 Identification of programmed cell death in situvia specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501
17. Gittoes NJ, Bates AS, Tse W, Bullivant B, Sheppard MC, Clayton RN, Stewart PM 1998 Radiotherapy for non-function pituitary tumors. Clin Endocrinolm (Oxf) 48: 331-337
18. Green VL, White MC, Hipkin LJ, Jeffreys RV, Foy PM, Atkin SL 1997 Apoptosis and p53 suppressor gene protein expression in human anterior pituitary adenomas. Eur J Endocrinol 136: 382-387
19. Kitz K, Knosp E, Koos WT, Korn A 1991 Proliferation in pituitary adenomas: measurement by MAb KI 67. Acta Neurochir (Wien) 53 (Suppl): 60-64
20. Knosp E, Kitz K, Perneczky A 1989 Proliferation activity in pituitary adenomas: measurement by monoclonal antibody Ki-67. Neurosurgery 25: 927-930
21. Kovacs K, Horvath E 1986 Atlas of Tumor Pathology: Tumors of the pituitary gland (Second Series, Fascicle 21). Bremen, Lanham
22. Kulig E, Jin L, Qian X, Horvath E, Kovacs K, Stefaneanu L, Scheithauer BW, Lloyd RV 1999 Apoptosis in nontumorous and neoplastic human pituitaries: expression of the Bcl-2 family of proteins. Am J Pathol 154: 767-774
23. Landolt AM, Shibata T, Kleihues P 1987 Growth rate of human pituitary adenomas. J Neurosurg 67: 803-806
24. Leers MP, Kolgen W, Bjorklund V, Bergman T, Tribbick G Persson B, Bjorklund P, Ramaekers, FC, Bjorklund B, Nap M, Jornvall H, Schutte B 1999 Immunocytochemical detection and mapping of a cytokeratin 18 neo-epitope exposed during early apoptosis. J Pathol 187: 567-572
25. Lillehei KO, Kirschman DL, Kleinschmidt-DeMasters BK, Ridgway EC 1998 Reassessment of the role of radiation therapy in the treatment of endocrine-inactive pituitary macroadenomas. Neurosurgery 43: 432-438
26. Liuzzi A, Tassi V, Pirro MT, Zingrillo M, Ghiggi MR, Chiodini I, Oppizzi G, Barberis M 1996 Non-functioning adenomas of the pituitary. Metabolism 45: 80-82
27. Mastronardi L, Guiducci A, Spera C, Puzzilli F, Liberati F, Maira G 1999 Ki-67 labelling index and invasiveness among anterior pituitary adenomas: analysis of 103 cases using the MIB-1 monoclonal antibody. J Clin Pathol 52: 107-111
28. Mastronardi L, Guiducci A, Spera C, Puzzilli F, Liberati F, Ruggeri A, Peciarolo A 2000 Adrenocorticotropic hormone secreting pituitary adenomas: analysis of growth fraction using the MIB-1 antibody. Tumori 86: 229-232
29. Parkins CS, Darling JL, Gill SS, Revesz T, Thomas DG 1991 Cell proliferation in serial biopsies through human malignant brain tumors: measurement using Ki67 antibody labelling. Br J Neurosurg 5: 289-298
30. Pernicone PJ, Scheithauer BW 1993 Invasive pituitary adenomas and pituitary carcinomas. WB Saunders, Philadelphia, pp 121-136
31. Sahin AA, Ro J, Ro JY, Blick MB, el Naggar AK, Ordonez NG, Fritsche HA, Smith TL, Hortobagyi GN, Ayala AG 1991 Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis. Cancer 68: 549-557
32. Sautner D, Saeger W 1991 Invasiveness of pituitary adenomas. Pathol Res Pract 187: 632-636
33. Scheithauer BW, Kovacs KT, Laws ER Jr, Randall RV 1986 Pathology of invasive pituitary tumors with special reference to functional classification. J Neurosurg 65: 733-744
34. Shibuya M, Saito F, Miwa T, Davis RL, Wilson CB, Hoshino T 1992 Histochemical study of pituitary adenomas with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nucleolar organizer region counts. Acta Neuropathol (Berl) 84: 178-183
35. Soini Y, Virkajarvi N, Lehto VP, Paakko P 1996 Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival. Br J Cancer 73: 1025-1030
36. Thapar K, Kovacs K, Scheithauer BW, Stefaneanu L, Horvath E, Pernicone PJ, Murray D, Laws ER Jr 1996 Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery 38: 99-106
37. Yeh PJ, Chen JW 1997 Pituitary tumors: surgical and medical management. Surg Oncol 6: 67-92